Clincosm LogoSign in Get a demo

Rhabdomyosarcoma

Showing 1 - 25 of 85
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

Recruiting
  • Ewing Sarcoma
  • +2 more
  • Peptide vaccine IPX
  • Frankfurt am Main, Germany
  • +2 more
Oct 18, 2023

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Not yet recruiting
  • Rhabdomyosarcoma
    • San Francisco, California
      Power Life Sciences
    Sep 1, 2023

    Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

    Not yet recruiting
    • Rhabdomyosarcoma
    • Palo Alto, California
    • +2 more
    Aug 27, 2023

    Solid Tumors, Neuroblastoma, Rhabdomyosarcoma Trial in Durham, Cincinnati (VAL-413, Temozolomide)

    Recruiting
    • Solid Tumors
    • +5 more
    • Durham, North Carolina
    • +2 more
    Jan 31, 2023

    Lung Cancer, Ovarian Cancer, Uterine Cancer Trial in United States (OmniSeq Test)

    Recruiting
    • Lung Cancer
    • +12 more
    • OmniSeq Test
    • Fort Payne, Alabama
    • +7 more
    Jan 16, 2023

    Rhabdomyosarcoma Trial in Sutton, Manchester (Irinotecan, Actinomycin D, Doxorubicin)

    Recruiting
    • Rhabdomyosarcoma
    • Camperdown, Australia
    • +89 more
    Jan 3, 2023

    Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

    Recruiting
    • Liver Cell Carcinoma
    • +7 more
    • CATCH T cells
    • +2 more
    • Houston, Texas
      Houston Methodist Hospital
    Dec 19, 2022

    Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

    Completed
    • Ependymoma
    • +9 more
    • Nivolumab
    • NKTR-214
    • Little Rock, Arkansas
    • +17 more
    Dec 8, 2022

    Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcoma Trial in United States (Regorafenib, Placebo)

    Completed
    • Liposarcoma
    • +4 more
    • Duarte, California
    • +17 more
    Oct 25, 2022

    Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

    Recruiting
    • Ewing Sarcoma
    • +5 more
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022

    Desmoplastic Small Round Cell Tumor, Rhabdomyosarcoma Trial in New York (Prexasertib, Irinotecan)

    Active, not recruiting
    • Desmoplastic Small Round Cell Tumor
    • Rhabdomyosarcoma
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 3, 2022

    Participated in Children's Oncology Group Studies

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +5 more
    • Assessment of Therapy Complications
    • Questionnaire Administration
    • Birmingham, Alabama
    • +163 more
    Sep 6, 2022

    Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

    Not yet recruiting
    • Sarcoma, Ewing
    • Rhabdomyosarcoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

    Recruiting
    • Ewing Sarcoma
    • +6 more
    • Birmingham, Alabama
    • +83 more
    Aug 19, 2022

    Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma Trial in Worldwide (drug,

    Suspended
    • Alveolar Rhabdomyosarcoma
    • +5 more
    • Birmingham, Alabama
    • +386 more
    Aug 18, 2022

    Drug Sensitivity and Mutation Profiling

    Recruiting
    • Ewing Sarcoma
    • +6 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Aug 5, 2022

      Collecting and Storing Tissue From Young Patients With Cancer

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +13 more
      • Cytology Specimen Collection Procedure
      • Laboratory Biomarker Analysis
      • Birmingham, Alabama
      • +68 more
      Aug 4, 2022

      Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old

      Active, not recruiting
      • Rhabdomyosarcoma
        • Bordeaux, France
        • +19 more
        Jul 19, 2022

        Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

        Recruiting
        • Pediatric Solid Tumor
        • +15 more
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Jun 30, 2022

        Pediatric Renal Tumor, Metastatic Osteosarcoma, Metastatic Ewing Sarcoma Trial in Birmingham (Indocyanine green)

        Recruiting
        • Pediatric Renal Tumor
        • +5 more
        • Indocyanine green
        • Birmingham, United Kingdom
          Birmingham children's hospital
        Jun 27, 2022

        Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin

        Completed
        Has Results
        • Refractory or Recurrent Solid Tumors
        • +3 more
        • Eribulin mesilate
        • Irinotecan hydrochloride
        • Marseille, Bouches-du-Rhône, France
        • +38 more
        Jun 20, 2022

        Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

        Active, not recruiting
        • Adrenal Cortex Carcinoma
        • +39 more
        • Birmingham, Alabama
        • +142 more
        May 24, 2022

        Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)

        Recruiting
        • Rhabdomyosarcoma
        • Los Angeles, California
          UCLA / Jonsson Comprehensive Cancer Center
        May 13, 2022

        Familial Investigations of Childhood Cancer Predisposition

        Recruiting
        • Acute Leukemia
        • +45 more
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          May 11, 2022

          Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

          Recruiting
          • Pediatric Solid Tumor
          • +15 more
          • second generation 4-1BBζ EGFR806-EGFRt
          • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
          • Seattle, Washington
            Seattle Children's Hospital
          May 2, 2022